AllQuantitative Report
logoArgusOctober 21, 2020

GKOS: Raising target price to $45.00

Symbols
GKOS
Sector(s)
Healthcare
Rating
Premium
Current Price
$68.85
Price Target
$NaN
Earnings Estimate
Premium
Summary

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE